Mukka Proteins Ltd (MUKKA) is currently trading at 29.73 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Mukka Proteins Limited is an integrated marine- and alternative-protein company that manufactures and exports fishmeal, fish oil, fish soluble paste, and operates a growing Black Soldier Fly (BSF) insect-protein and waste-to-value platform, alongside frozen seafood and leachate treatment businesses, with manufacturing assets in India and Oman and a large export footprint across 25+ countries. Q3 FY26 showed a large top-line spike to ₹653.5 crore versus ₹244.6 crore in Q2 FY26 and ₹303.2 crore in Q3 FY25, reflecting consolidation of recent acquisitions, a sizeable leachate order recognition and strong export demand; however EBITDA margins compressed to 8.1% in Q3 indicating mix and project execution impacts on profitability. The company holds approximately 25–30% market share of Indian fishmeal and fish oil exports, with exports contributing 75.7% of 9MFY26 revenue; Mukka combines coastal strategic assets, backward-integration plans, and Oman operations to secure raw material access and serve global aquaculture, poultry and pet-food markets with custom formulations and high-protein output. Sustainability and circular-economy initiatives are central: Mukka reports over 100,000 tonnes wet-waste diverted, formal Verra registry listing for BSF operations, incremental approvals to expand wet-waste processing to 1,000 TPD, and a major ₹474.89 crore leachate remediation contract that positions the company to monetise carbon credits and annuity-style municipal revenues.

Over the past 52 weeks, Mukka Proteins Ltd has traded between a low of ₹18.32 and a high of ₹33.24. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Mukka Proteins Ltd has a market capitalization of approximately 912.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Mukka Proteins Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 912.00 Cr, Mukka Proteins Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Mukka Proteins Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Mukka Proteins Ltd is 12.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Mukka Proteins reported consolidated PAT of ₹18.63 crore (₹186.34 million) for the quarter ended June 30, 2026.

CESTAT Bengaluru set aside a customs duty demand of ₹152.43 million, holding that the Customs Department failed to prove undervaluation with cogent evidence.

Mukka Proteins has proposed issuing up to 2,00,00,000 convertible warrants on a preferential basis at Rs 23.50 per warrant, aggregating Rs 47 crore.

It is an entirely fresh issue of up to 8 crore equity shares with a face value of Re 1, with no offer-for-sale component mentioned in the provided details.